Correlation Between Diamyd Medical and ExpreS2ion Biotech
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and ExpreS2ion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and ExpreS2ion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and ExpreS2ion Biotech Holding, you can compare the effects of market volatilities on Diamyd Medical and ExpreS2ion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of ExpreS2ion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and ExpreS2ion Biotech.
Diversification Opportunities for Diamyd Medical and ExpreS2ion Biotech
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Diamyd and ExpreS2ion is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and ExpreS2ion Biotech Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ExpreS2ion Biotech and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with ExpreS2ion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ExpreS2ion Biotech has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and ExpreS2ion Biotech go up and down completely randomly.
Pair Corralation between Diamyd Medical and ExpreS2ion Biotech
Assuming the 90 days trading horizon Diamyd Medical AB is expected to generate 0.81 times more return on investment than ExpreS2ion Biotech. However, Diamyd Medical AB is 1.24 times less risky than ExpreS2ion Biotech. It trades about 0.07 of its potential returns per unit of risk. ExpreS2ion Biotech Holding is currently generating about -0.27 per unit of risk. If you would invest 1,306 in Diamyd Medical AB on September 3, 2024 and sell it today you would earn a total of 54.00 from holding Diamyd Medical AB or generate 4.13% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Diamyd Medical AB vs. ExpreS2ion Biotech Holding
Performance |
| Timeline |
| Diamyd Medical AB |
| ExpreS2ion Biotech |
Diamyd Medical and ExpreS2ion Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diamyd Medical and ExpreS2ion Biotech
The main advantage of trading using opposite Diamyd Medical and ExpreS2ion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, ExpreS2ion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ExpreS2ion Biotech will offset losses from the drop in ExpreS2ion Biotech's long position.| Diamyd Medical vs. Cantargia AB | Diamyd Medical vs. Hansa Biopharma AB | Diamyd Medical vs. Saniona AB | Diamyd Medical vs. Mendus AB |
| ExpreS2ion Biotech vs. Bavarian Nordic | ExpreS2ion Biotech vs. BioPorto | ExpreS2ion Biotech vs. Zaptec AS | ExpreS2ion Biotech vs. cBrain AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |